Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eli Lilly & Co (DE:LLY)
XETRA:LLY
Holding DE:LLY?
Track your performance easily
See the Price Targets and Ratings of:
LLY Analyst Ratings
Strong Buy
17 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LLY Stock 12 Month Forecast
Average Price Target
€995.29
▲(38.10% Upside)
| Highest Price Target€1,194 | Average Price Target€995.29 | Lowest Price Target€845.22 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wells Fargo
Reiterated
11/20/24
Leerink Partners
Reiterated
11/19/24
Barclays
Assigned
11/18/24
BMO Capital
Reiterated
11/18/24
Evercore ISI
Assigned
11/18/24
Wolfe Research
Initiated
11/14/24
Truist Financial
Reiterated
11/05/24
Deutsche Bank
Assigned
11/04/24
Bank of America Securities
Assigned
11/01/24
Jefferies
Assigned
10/31/24
Morgan Stanley
€1,105.95→€1,094.49
Buy
51.87%
Upside
Reiterated
10/31/24
Analysts Offer Insights on Healthcare Companies: Bausch + Lomb Corporation (NYSE: BLCO), Ginkgo Bioworks Holdings (NYSE: DNA) and Eli Lilly & Co (NYSE: LLY)
J.P. Morgan
€1,050.56
Buy
45.77%
Upside
Reiterated
10/30/24
Eli Lilly core thesis 'remains intact' despite Q3 miss, says JPMorganEli Lilly core thesis 'remains intact' despite Q3 miss, says JPMorgan
Citi
€1,012.36→€1,193.82
Buy
65.65%
Upside
Reiterated
10/25/24
Eli Lilly price target raised to $1,250 from $1,060 at CitiEli Lilly price target raised to $1,250 from $1,060 at Citi
Bernstein
€1,050.56
Buy
45.77%
Upside
Initiated
10/17/24
Eli Lilly initiated with an Outperform at BernsteinEli Lilly initiated with an Outperform at Bernstein
DBS
―
Buy
―
Reiterated
10/15/24
Eli Lilly: A Strong Buy on Robust Revenue Growth and Expanding Market Potential
Best Analysts Covering Eli Lilly & Co
Which Analyst Should I Follow If I Want to Buy DE:LLY and Sell After:
1 Month
xxx
Success Rate
26/34 ratings generated profit
Average Return
+5.37%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 76.47% of your transactions generating a profit, with an average return of +5.37% per trade.
3 Months
xxx
Success Rate
27/34 ratings generated profit
Average Return
+10.76%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 79.41% of your transactions generating a profit, with an average return of +10.76% per trade.
1 Year
Success Rate
32/37 ratings generated profit
Average Return
+35.73%
reiterated a buy rating 2 months ago
Copying Louise Chen's trades and holding each position for 1 Year would result in 86.49% of your transactions generating a profit, with an average return of +35.73% per trade.
2 Years
xxx
Success Rate
33/37 ratings generated profit
Average Return
+74.82%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 89.19% of your transactions generating a profit, with an average return of +74.82% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LLY Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
0
0
0
0
0
Buy
61
71
67
73
53
Hold
11
11
13
6
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
72
82
80
79
56
Each month's total comprises the sum of three months' worth of ratings.
LLY Financial Forecast
LLY Stock Forecast FAQ
What is DE:LLY’s average 12-month price target, according to analysts?
Based on analyst ratings, Eli Lilly & Co’s 12-month average price target is €995.29.
What is DE:LLY’s upside potential, based on the analysts’ average price target?
Eli Lilly & Co has 38.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Eli Lilly & Co a Buy, Sell or Hold?
Eli Lilly & Co has a consensus rating of Strong Buy, which is based on 17 buy ratings, 1 hold ratings and 0 sell ratings.
What is Eli Lilly & Co’s share price target?
The average share price target for Eli Lilly & Co is €995.29. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €1,193.82 ,and the lowest forecast is €845.22. The average share price target represents 38.10% Increase from the current price of €720.7.
The highest analyst share price target is €1,193.82 ,and the lowest forecast is €845.22. The average share price target represents 38.10% Increase from the current price of €720.7.
What do analysts say about Eli Lilly & Co?
Eli Lilly & Co’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
How can I buy shares of Eli Lilly & Co?
To buy shares of DE:LLY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.